Bas C. Stunnenberg

641 total citations
21 papers, 339 citations indexed

About

Bas C. Stunnenberg is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Bas C. Stunnenberg has authored 21 papers receiving a total of 339 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 12 papers in Cellular and Molecular Neuroscience and 12 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Bas C. Stunnenberg's work include Ion channel regulation and function (11 papers), Genetic Neurodegenerative Diseases (11 papers) and Cardiac electrophysiology and arrhythmias (9 papers). Bas C. Stunnenberg is often cited by papers focused on Ion channel regulation and function (11 papers), Genetic Neurodegenerative Diseases (11 papers) and Cardiac electrophysiology and arrhythmias (9 papers). Bas C. Stunnenberg collaborates with scholars based in Netherlands, United States and United Kingdom. Bas C. Stunnenberg's co-authors include Gea Drost, Baziel G.M. van Engelen, Gert Jan van der Wilt, Jeffrey Statland, Robert C. Griggs, Joost Raaphorst, Emma Matthews, Jaya Trivedi, Dick F. Stegeman and Hans Groenewoud and has published in prestigious journals such as JAMA, Neurology and Epilepsia.

In The Last Decade

Bas C. Stunnenberg

21 papers receiving 331 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bas C. Stunnenberg Netherlands 10 192 149 139 49 42 21 339
J. Trip Netherlands 10 260 1.4× 244 1.6× 178 1.3× 12 0.2× 63 1.5× 13 357
Jinxian Yuan China 10 101 0.5× 63 0.4× 29 0.2× 17 0.3× 68 1.6× 19 320
Emily Tu Australia 7 149 0.8× 73 0.5× 189 1.4× 4 0.1× 17 0.4× 18 363
Giordano Cecchetti Italy 10 62 0.3× 45 0.3× 32 0.2× 10 0.2× 88 2.1× 35 388
Holly R. Robertson United States 8 165 0.9× 154 1.0× 17 0.1× 16 0.3× 2 0.0× 12 295
Tony Lin United States 5 214 1.1× 153 1.0× 109 0.8× 2 0.0× 19 0.5× 5 320
Toru Nabika Japan 10 126 0.7× 26 0.2× 52 0.4× 9 0.2× 67 1.6× 23 315
Katie Chapman United Kingdom 8 87 0.5× 66 0.4× 10 0.1× 14 0.3× 25 0.6× 11 401
R G Hart United States 5 55 0.3× 151 1.0× 8 0.1× 11 0.2× 215 5.1× 5 321
Maria Julia Machline Carrion Brazil 4 35 0.2× 19 0.1× 5 0.0× 33 0.7× 28 0.7× 5 178

Countries citing papers authored by Bas C. Stunnenberg

Since Specialization
Citations

This map shows the geographic impact of Bas C. Stunnenberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bas C. Stunnenberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bas C. Stunnenberg more than expected).

Fields of papers citing papers by Bas C. Stunnenberg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bas C. Stunnenberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bas C. Stunnenberg. The network helps show where Bas C. Stunnenberg may publish in the future.

Co-authorship network of co-authors of Bas C. Stunnenberg

This figure shows the co-authorship network connecting the top 25 collaborators of Bas C. Stunnenberg. A scholar is included among the top collaborators of Bas C. Stunnenberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bas C. Stunnenberg. Bas C. Stunnenberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tjepkema‐Cloostermans, Marleen C., Martijn R. Tannemaat, Luuk Wieske, et al.. (2024). Expert level of detection of interictal discharges with a deep neural network. Epilepsia. 66(1). 184–194. 3 indexed citations
2.
Thiel, Ghislaine J. M. W. van, Willem M. Otte, Roger E. G. Schutgens, et al.. (2023). Toward responsible clinical n-of-1 strategies for rare diseases. Drug Discovery Today. 28(10). 103688–103688. 15 indexed citations
3.
Meinders, Marjan J., Federica Giardina, Kit C. B. Roes, et al.. (2022). Multiple N-of-1 trials to investigate hypoxia therapy in Parkinson’s disease: study rationale and protocol. BMC Neurology. 22(1). 262–262. 9 indexed citations
4.
Stunnenberg, Bas C., Robert C. Griggs, Jeffrey Statland, et al.. (2021). N-of-1 Trials in Neurology. Neurology. 98(2). e174–e185. 8 indexed citations
5.
Visser, Saco J. de, Bas C. Stunnenberg, Lonneke Timmers, et al.. (2021). Cost-Based Price Calculation of Mexiletine for Nondystrophic Myotonia. Value in Health. 24(7). 925–929. 11 indexed citations
6.
Stunnenberg, Bas C., Samantha LoRusso, W. David Arnold, et al.. (2020). Guidelines on clinical presentation and management of nondystrophic myotonias. Muscle & Nerve. 62(4). 430–444. 46 indexed citations
7.
Stunnenberg, Bas C., Jaap Deinum, Tom Nijenhuis, et al.. (2020). N-of-1 Trials: Evidence-Based Clinical Care or Medical Research that Requires IRB Approval? A Practical Flowchart Based on an Ethical Framework. Healthcare. 8(1). 49–49. 23 indexed citations
8.
Stunnenberg, Bas C., et al.. (2020). Novel SCN9A Mutations in a Compound Heterozygous Girl with Congenital Insensitivity to Pain. Journal of Pediatric Neurology. 19(3). 189–192. 1 indexed citations
9.
Stunnenberg, Bas C., Joost Raaphorst, Johanna C.W. Deenen, et al.. (2018). Prevalence and mutation spectrum of skeletal muscle channelopathies in the Netherlands. Neuromuscular Disorders. 28(5). 402–407. 40 indexed citations
10.
Stunnenberg, Bas C., Joost Raaphorst, Hans Groenewoud, et al.. (2018). A series of aggregated randomized-controlled N-of-1 trials with mexiletine in non-dystrophic myotonia: clinical trial results and validation of rare disease design (P3.440). Neurology. 90(15_supplement). 1 indexed citations
11.
Stunnenberg, Bas C., et al.. (2018). Prolonged attacks of weakness with hypokalemia in SCN4A‐related paramyotonia congenita. Muscle & Nerve. 58(4). E27–E28. 6 indexed citations
12.
Stunnenberg, Bas C., Joost Raaphorst, Hans Groenewoud, et al.. (2018). Effect of Mexiletine on Muscle Stiffness in Patients With Nondystrophic Myotonia Evaluated Using Aggregated N-of-1 Trials. JAMA. 320(22). 2344–2344. 85 indexed citations
13.
Vlijmen, Bas van, Hans Groenewoud, Gert Jan van der Wilt, et al.. (2018). Individual N-of-1 Trial Salbutamol Versus Placebo as Attack Treatment in a Patient with Hyperkalemic Periodic Paralysis (P3.455). Neurology. 90(15_supplement). 1 indexed citations
14.
Stunnenberg, Bas C., Benno Küsters, Erik‐Jan Kamsteeg, et al.. (2016). A novel Ile1455Thr variant in the skeletal muscle sodium channel alpha-subunit in a patient with a severe adult-onset proximal myopathy with electrical myotonia and a patient with mild paramyotonia phenotype. Neuromuscular Disorders. 27(2). 175–182. 7 indexed citations
15.
Stunnenberg, Bas C., Willem Woertman, Joost Raaphorst, et al.. (2015). Combined N-of-1 trials to investigate mexiletine in non-dystrophic myotonia using a Bayesian approach; study rationale and protocol. BMC Neurology. 15(1). 43–43. 18 indexed citations
16.
Stunnenberg, Bas C., et al.. (2014). Clinical Experience With Long-Term Acetazolamide Treatment in Children With Nondystrophic Myotonias: A Three-Case Report. Pediatric Neurology. 51(4). 537–541. 20 indexed citations
17.
Drost, Gea, Bas C. Stunnenberg, J. Trip, et al.. (2014). Myotonic discharges discriminate chloride from sodium muscle channelopathies. Neuromuscular Disorders. 25(1). 73–80. 9 indexed citations
18.
Stunnenberg, Bas C. & Gea Drost. (2014). Teaching Video Neuro Images : Lid lag sign and diplopia in paramyotonia congenita. Neurology. 83(5). e68–e68. 4 indexed citations
19.
Stunnenberg, Bas C., H.B. Ginjaar, J. Trip, et al.. (2009). Isolated eyelid closure myotonia in two families with sodium channel myotonia. Neurogenetics. 11(2). 257–260. 20 indexed citations
20.
Sie, L.T.L., et al.. (2009). G.P.14.10 Clinical experience with acetazolamide treatment in children; good response in both sodium and chloride channelopathies. Neuromuscular Disorders. 19(8-9). 646–646. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J. Trip Breakdown of academic impact, for papers by Jinxian Yuan Breakdown of academic impact, for papers by Emily Tu Breakdown of academic impact, for papers by Giordano Cecchetti Breakdown of academic impact, for papers by Holly R. Robertson Breakdown of academic impact, for papers by Tony Lin Breakdown of academic impact, for papers by Toru Nabika Breakdown of academic impact, for papers by Katie Chapman Breakdown of academic impact, for papers by R G Hart Breakdown of academic impact, for papers by Maria Julia Machline Carrion
Rankless by CCL
2026